210 related articles for article (PubMed ID: 16935796)
61. Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: results of a multicenter 6-week dose-response trial.
Marks R; Gebauer K; Shumack S; Amies M; Bryden J; Fox TL; Owens ML;
J Am Acad Dermatol; 2001 May; 44(5):807-13. PubMed ID: 11312429
[TBL] [Abstract][Full Text] [Related]
62. Methotrexate-induced necrolysis in tumoral-stage mycosis fungoides: a challenging diagnosis.
Mna AB; Souissi A; Halouani S; El Euch D; Zahani A; Kchir N; Zaraa I; Mokni M
Dermatol Online J; 2016 Jan; 22(1):. PubMed ID: 26990481
[TBL] [Abstract][Full Text] [Related]
63. Alemtuzumab induced complete remission of romidepsin-refractory large cell transformation of mycosis fungoides.
Kwong YL
Ann Hematol; 2014 Apr; 93(4):713-4. PubMed ID: 23934231
[No Abstract] [Full Text] [Related]
64. CD30 As a Target for the Treatment of Cutaneous T-Cell Lymphoma.
Prince HM
J Clin Oncol; 2015 Nov; 33(32):3691-6. PubMed ID: 26392103
[TBL] [Abstract][Full Text] [Related]
65. Primary cutaneous CD30+ anaplastic large cell lymphoma responds to imiquimod cream.
Ehst BD; Dréno B; Vonderheid EC
Eur J Dermatol; 2008; 18(4):467-8. PubMed ID: 18573730
[No Abstract] [Full Text] [Related]
66. Mycosis fungoides lymphoma.
Van Scott EJ
Clin Pharmacol Ther; 1974 Nov; 16(5 Part 2):931-3. PubMed ID: 4424203
[No Abstract] [Full Text] [Related]
67. Chlormethine Gel in Combination with Other Therapies in the Treatment of Patients with Mycosis Fungoides Cutaneous T Cell Lymphoma: Three Case Reports.
Lampadaki K; Koumourtzis M; Karagianni F; Marinos L; Papadavid E
Adv Ther; 2021 Jun; 38(6):3455-3464. PubMed ID: 33928511
[TBL] [Abstract][Full Text] [Related]
68. Treatment of cutaneous T-cell lymphoma (mycosis fungoides) with 13-cis-retinoic acid.
Kessler JF; Meyskens FL; Levine N; Lynch PJ; Jones SE
Lancet; 1983 Jun; 1(8338):1345-7. PubMed ID: 6134133
[TBL] [Abstract][Full Text] [Related]
69. Using topical imiquimod for the management of positive in situ margins after melanoma resection.
Pandit AS; Geiger EJ; Ariyan S; Narayan D; Choi JN
Cancer Med; 2015 Apr; 4(4):507-12. PubMed ID: 25620351
[TBL] [Abstract][Full Text] [Related]
70. Response of CD30+ large cell lymphoma of skin to bexarotene.
Keun YK; Woodruff R; Sangueza O
Leuk Lymphoma; 2002 May; 43(5):1153-4. PubMed ID: 12148901
[TBL] [Abstract][Full Text] [Related]
71. Topical treatment of cutaneous Kaposi sarcoma with imiquimod 5% in renal-transplant recipients: a clinicopathological observation.
Prinz Vavricka BM; Hofbauer GF; Dummer R; French LE; Kempf W
Clin Exp Dermatol; 2012 Aug; 37(6):620-5. PubMed ID: 22300351
[TBL] [Abstract][Full Text] [Related]
72. Pilot Study of a Novel Therapeutic Approach for Refractory Advanced Stage Folliculotropic Mycosis Fungoides.
Del Guzzo CA; Jariwala NN; Haun PL; MacArthur KM; Mowad CM; Richard EG; Holton JP; Rook AH
Acta Derm Venereol; 2020 Jun; 100(13):adv00187. PubMed ID: 32128597
[TBL] [Abstract][Full Text] [Related]
73. Interferon in the treatment of cutaneous T-cell lymphoma.
Olsen EA
Dermatol Ther; 2003; 16(4):311-21. PubMed ID: 14686974
[TBL] [Abstract][Full Text] [Related]
74. Imiquimod for the treatment of skin cancer.
Burns CA; Brown MD
Dermatol Clin; 2005 Jan; 23(1):151-64, vii. PubMed ID: 15620626
[TBL] [Abstract][Full Text] [Related]
75. RF - Brentuximab as Treatment for CD30
Morgado-Carrasco D; Combalia A; Estrach Panella T
Actas Dermosifiliogr (Engl Ed); 2019 Nov; 110(9):769-770. PubMed ID: 31151669
[No Abstract] [Full Text] [Related]
76. Complete remission of cutaneous and subcutaneous melanoma metastases of the scalp with imiquimod therapy.
Heber G; Helbig D; Pönitzsch I; Wetzig T; Harth W; Simon JC
J Dtsch Dermatol Ges; 2009 Jun; 7(6):534-6. PubMed ID: 19250248
[TBL] [Abstract][Full Text] [Related]
77. Interferon alpha and etretinate combination treatment of cutaneous T-cell lymphoma.
Zachariae H; Thestrup-Pedersen K
J Invest Dermatol; 1990 Dec; 95(6 Suppl):206S-208S. PubMed ID: 2258637
[TBL] [Abstract][Full Text] [Related]
78. Transformed cutaneous T cell lymphoma and biclonal gammopathy.
Miralles ES; Núñez M; Boixeda P; Moreno R; Bellas C; Ledo A
Int J Dermatol; 1996 Mar; 35(3):196-8. PubMed ID: 8655237
[No Abstract] [Full Text] [Related]
79. Treatment of cutaneous T-cell lymphoma with the arotinoid Ro 13-6298.
Tousignant J; Raymond GP; Light MJ
J Am Acad Dermatol; 1987 Jan; 16(1 Pt 2):167-71. PubMed ID: 3493269
[TBL] [Abstract][Full Text] [Related]
80. Topical imiquimod monotherapy for indolent primary cutaneous B-cell lymphomas: a single-institution experience.
Hwang S; Johnson A; Fabbro S; Hastings J; Haverkos B; Chung C; Porcu P; William B
Br J Dermatol; 2020 Aug; 183(2):386-387. PubMed ID: 32078154
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
